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OBJECTIVES: Compare direct and indirect (workloss) costs between privately-in-
suredU.S. employeeswith hypogonadism (HG) and demographicallymatched con-
trols without HG. METHODS: Male employees, ages 35-64, with 2 HG diagnoses
(ICD-9-CM: 257.2x) or 1 HG diagnosis and 1 claim for testosterone therapy be-
tween 1/1/2005-3/31/2009were identified from a privately-insured claims database
(N12,000,000). The index date was defined as the most recent HG diagnosis with
continuous eligibility 1 year before (baseline period) and 1 year after (study pe-
riod). EmployeeswithHGwerematched 1:1 on age, region, employment status, and
index year to controls without HG. Descriptive analyses compared demographic
characteristics, comorbidities, resource utilization, direct costs (reimbursements
to providers for medical services and prescription drugs) and indirect costs (dis-
ability andmedically-related absenteeism) inflated to $2009. Multivariate analyses
adjusting for baseline patient differences were used to estimate risk-adjusted
costs. RESULTS: 4,269 HG employees, mean age 51, with matched controls met
inclusion criteria. Compared with controls, HG employees had higher baseline co-
morbidity rates: hyperlipidemia (50.2% vs. 25.3%), hypertension (37.7% vs. 21.1%),
back/neck pain (32.0% vs. 15.7%), and HIV/AIDS (7.1% vs. 0.3%) (all p0.0001). HG
employees had higher study period rates of inpatient stays (10.8% vs. 5.2%), Emer-
gency Department visits (27.5% vs. 16.3%), outpatient visits (100.0% vs. 76.7%), pre-
scriptionmedication use (95.7% vs. 68.3%), and highermeanworkloss days (19.3 vs.
8.8) (all p0.0001). HG employees compared with controls had higher mean study
period direct ($10,914 vs. $3,823) and indirect costs ($3,204 vs. $1,450); HG-related
direct costs were $832. HG employees’ costs remained higher after adjusting for
baseline differences (direct: $9,291 vs. $5,248; indirect: $2,729 vs. $1,840) (all
p0.0001). CONCLUSIONS: Employees with HG had higher comorbidity rates and
costs comparedwith demographicallymatched controls. Given the lowHG-related
costs, themain driver of overall costs among HG patientsmay be their comorbidity
burden.
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OBJECTIVES: To assess associations between joblessness and all-cause emergency
department (ED), hospitalization, outpatient and office-based health services uti-
lization in US diabetic working-age adults. METHODS: This retrospective longitu-
dinal panel design used nationally-representative 2001 – 2007 pooled public do-
main complete panel data from the Medical Expenditure Panel Survey (MEPS).
Eligible MEPS respondents aged 24–59 years with an ICD-9-CM diabetes diagnostic
code “250”, were included. Those with pregnancy diagnostic codes, seasonal job
status, or prescribed insulin were excluded. Subjects reporting an employment
status as “not employed with no job to return to” were classified as jobless. Using
MEPSweights to account for the complex survey design, logistic regressionmodels
estimated associations between joblessness and the likelihood of utilization. Neg-
ative binomial regression models assessed number of utilizations. The Taylor lin-
earization method estimated variance. RESULTS: 2,678 subjects (means: age 48.7
years [SD 0.28], BMI 31.5 [SD 0.30], Charlson Comorbidity Index 0.369 [SD 0.12]) met
eligibility criteria. Compared to those employed, joblessness significantly in-
creased the odds for all-cause ED utilization 64% (OR 1.64, p 0.007) outpatient
visits 46% (OR 1.46, p 0.011) and office-based visit 45%, (OR 1.45, p 0.009). Job-
lessness was associated with higher logs of expected counts for ED visits ( 0.43,
p 0.005) outpatient visits ( 0.49, p 0.002), and office-based visits 41% ( 0.41,
p0.000). The following covariates showed significant (p0.05) associations across
ED, hospitalization, outpatient and office-based utilization sectors: family size, age,
the Charlson Comorbidity Index, and the presence of one or more diabetes related
complication. Hispanic ethnicitywas associatedwith fewer ED visits (0.51, p
0.001), and fewer hospitalizations ( 0.41, p  0.026) than other ethnicities.
Though non-significant, compared to uninsured individuals, private and public
health insurance coverage also showed increased odds and number of utilizations.
CONCLUSIONS: Joblessness was significantly associated with increased all-cause
health services utilization.
PODIUM SESSION I:
CASE STUDIES IN ADDRESSING SELECTION BIAS
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OBJECTIVES: Endogeneity is a common problem in retrospective claims data stud-
ies because patients in claims data were not assigned to treatment by randomiza-
tion. Propensity score matching (PSM), instrumental variables (IV), and difference-
in-difference (DID) have been used to control for selection bias in evaluating the
impact of treatment on outcome measures. This study compares the estimated
incremental costs between typical and atypical antipsychotic medication users in
patients with schizophrenia using these three methods. METHODS: Patients ages
18-64 years old with at least one prescription of typical or atypical antipsychotic
medication and at least one diagnosis claim of schizophrenia (ICD-9-CM diagnosis
295.xx) within 90 days of the antipsychotic medication were identified in Market-
Scan®Multi-State Medicaid Database 2002–2009. The index date was the first pre-
scription date of antipsychotic medication. All patients had 12-month continu-
ous enrollment prior to and post the index date. Outcomes were total all-cause
expenditures and psychiatric-related expenditures during the 12-month follow up.
The incremental costs associated with the use of typical antipsychotic medication
versus atypical medication was estimated using six regression models–three esti-
mation methods (GLM, IV, and DID) on two samples (matched and non-matched
sample). IV was prescribing physicians’ characteristics. RESULTS: A total of 447
atypical and 4544 typical antipsychotic usersmet all study criteria, with amean age
of 38.9. Five out of the six models (with the exception of the DID model on the
unmatched sample) did not find a significant relationship between types of anti-
psychotic medications and total costs, and five out of the six models (with the
exception of the IV model on the full unmatched sample) found atypical medica-
tion users had significantly higher psychiatric-related costs than typical medica-
tion users. CONCLUSIONS: The PS-based approach combined with the DID or IV
methods may be better than each approach alone.
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OBJECTIVES: Abundance of zero values is commonly observed in cost data result-
ing in skewed distribution. This analysis measured the inpatient cost and work-
place absenteeism associated with low back and neck pain and demonstrated the
consequences of ignoring zeros in inpatient cost and unreported absenteeism.
METHODS: We used employer-based claims from the Thomson Marketscan© Re-
search Database (2007), a database representing approximately 100 payers of insured
employees containing health and productivity management (HPM) and health care
utilization data. Adult insured employees with continuous eligibility in 2007 were
included. The ICD-9 codes identifiedmedical conditions including low back and neck
pain without (nociceptive pain, NOCI) or with a neuropathic component (mixed pain,
MIXED).Ordinary least squares (OLS) and two-stageTobit analyses evaluated themar-
ginal inpatient costs while OLS and Heckman’s Selection Bias (HSB) were applied to
absenteeism data. Estimated inpatient costs and absenteeism using OLS versus two-
stage techniques were compared. RESULTS: A total of 2,046,332 employees
(male59.2%; mean age 40.211.6 years) were analyzed. Hypertension (9.8%), NOCI
(9.5%), diabetes (3.7%), MIXED (3.0%) and depression (1.1%) were the most prevalent
medical conditions among these employees. 1,976,952 (96.6%) employees had no in-
patientepisodes, thus,withno inpatient costs.Mean inpatient cost for theentire study
population was $537.45 (median$0) versus $15,851.93 (median $8,302.20) among
thosewith inpatient episodes. The incremental inpatient costs associatedwithMIXED
andNOCIwere $1,333.0226.67 and $328.3615.63 usingOLS versus $2,478.97 [95%CI:
2,148.50 – 2,811.16] and $1,242.41 [95%CI: 1,020.10 – 1,469.18] using the two-stage Tobit.
Unreported absenteeism occurred in 80% of the employees. Annual absenteeism as-
sociated with MIXED and NOCI using OLS were 5.250.21 and 4.060.35 compared to
45.921.06 and 16.332.01 hours using the HSB technique. CONCLUSIONS: Ignoring
zeros in cost data and unreported absenteeismmay result in substantial underes-
timation of inpatient cost and workplace absenteeism associated with low back
and neck pain.
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OBJECTIVES: Abstraction of hospital records is currently underway at inpatient
psychiatric facilities across the United States to facilitate a large comparative ef-
fectiveness study with the following goals: 1) to observe and describe re-hospital-
ization patterns among patients with schizophrenia, and 2) to compare re-hospi-
talizaton outcomes between patients receiving paliperidone palmitate and those
receiving oral atypical antipsychotics. This abstract is intended to describe the
innovative design of this study.DESIGN/METHODS: This naturalistic record review
study incorporates several novel design elements and a unique two-phase abstrac-
tion process. In the first phase, all patients with a qualifying inpatient hospitaliza-
tion for schizophrenia are identified and basic demographic, clinical, and treat-
ment data is abstracted. From this pool of potentially-eligible patients, two groups
are identified; 1) patients discharged on paliperidone palmitate, and 2) patients
discharged on oral atypical antipsychotics. Random samples of patients are drawn
from each of these groups and designated for full data collection in phase two. In
the second review phase, these designated records are further abstracted to collect
detailed demographic variables, hospitalization and treatment history, condition
severity, comorbid conditions, and discharge characteristics. These variables are
used to model propensity scores for receipt of the target drug, and identify two
propensity-matched cohorts for the subsequent comparative effectiveness analy-
sis. Pilot testing at three hospitals has confirmed the availability of key data ele-
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